Net Cash Provided by (Used in) Operating Activities |
1.14 M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-1.28 M |
USD |
-117% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-704 K |
USD |
+28.7% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
1 B |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
13.6 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-838 K |
USD |
+28.8% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
24.2 M |
USD |
+21% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
2.9 M |
USD |
+6.2% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
21.1 M |
USD |
+15.3% |
Mar 31, 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
-2.8 M |
USD |
+0.99% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Current Income Tax Expense (Benefit) |
148 K |
USD |
+4.97% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
100 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
306 M |
USD |
0% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Depreciation, Depletion and Amortization |
4.03 M |
USD |
+1.62% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
2.3 M |
USD |
0% |
Mar 31, 2024 |
Q1 2024 |
Share-based Payment Arrangement, Expense |
0 |
USD |
-100% |
Dec 31, 2023 |
Q4 2023 |
Interest Expense |
17.6 M |
USD |
+17.9% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |